Company / Capital Expenditures
Humana Capital Expenditures History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Capital Expenditures
$546.0M
FY2025
5-year range
$546.0M / $1.3B
FY2021-FY2025
Trend
-5.0%
vs FY2024
Sector context
#21 of 150
Health Care
What the data says
Humana's capital expenditures of $546M is higher than 86% of companies in the Health Care sector (FY2025). Capital Expenditures has fluctuated over the past 10 years, ranging from $523M in FY2017 to $1.3B in FY2023.
Based on SEC 10-K filings.
$546M in FY2025 with a 5-year CAGR of -10.7%. Top quartile in the Health Care sector.
Declined from $1.3B to $546M over the past 2 years.
Health Care sector context is included.
Capital Expenditures over time
Growth rates
- 3-Year CAGR
- -17.3%
- 5-Year CAGR
- -10.7%
- 10-Year CAGR
- -
Sector benchmark
+101.4% above sector average
Key checks
Key Insights
- 5-year CAGR of -10.7%, indicating a declining trend.
- In FY2025, capital expenditures decreased 5.0% year-over-year.
- Ranks #21 out of 150 companies in the Health Care sector.
- Peak capital expenditures was recorded in FY2023.
Company context
Key Data Points
- Altman Z-Score 3.80 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Capital ExpendituresValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $546.0M | -5.0% |
| FY2024 | $575.0M | -57.2% |
| FY2023 | $1.3B | +39.2% |
| FY2022 | $964.0M | -28.2% |
| FY2021 | $1.3B | +39.2% |
| FY2020 | $964.0M | +84.0% |
| FY2019 | $524.0M | -14.4% |
| FY2018 | $612.0M | +17.0% |
| FY2017 | $523.0M | -0.8% |
| FY2016 | $527.0M | +19.5% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026